Product
STM-416
1 clinical trial
1 indication
Indication
Non-muscle-invasive Bladder CancerClinical trial
A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder CancerStatus: Recruiting, Estimated PCD: 2024-06-01